Yoshinaga Okugawa Selected Research

imidazoleacetic acid (IMAC)

1/2021	Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer.
1/2019	Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.
4/2018	Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinaga Okugawa Research Topics

Disease

69	Neoplasms (Cancer) 04/2022 - 04/2008
60	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 04/2008
31	Rectal Neoplasms (Rectal Cancer) 04/2021 - 10/2009
29	Neoplasm Metastasis (Metastasis) 11/2021 - 07/2009
19	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2010
15	Lymphatic Metastasis 01/2021 - 07/2009
10	Carcinogenesis 12/2018 - 02/2011
9	Inflammation (Inflammations) 01/2021 - 02/2014
9	Colonic Neoplasms (Colon Cancer) 12/2017 - 01/2007
8	Residual Neoplasm 10/2014 - 10/2009
6	Esophageal Neoplasms (Esophageal Cancer) 05/2021 - 11/2011
6	Ulcerative Colitis 01/2021 - 02/2014
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 01/2017
5	Disease Progression 04/2018 - 01/2003
3	Surgical Wound Infection 01/2021 - 01/2020
3	Sarcopenia 01/2021 - 04/2018
3	Adenoma (Adenomas) 12/2018 - 02/2011
2	Infections 01/2021 - 03/2015
2	Microsatellite Instability 01/2020 - 04/2016
2	Weight Loss (Weight Reduction) 01/2019 - 11/2018
2	Cachexia 11/2018 - 01/2017
2	Colitis 12/2017 - 05/2010
2	Esophageal Squamous Cell Carcinoma 01/2015 - 11/2011
2	Thrombosis (Thrombus) 01/2015 - 08/2011
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2014 - 02/2011
2	Peritoneal Neoplasms 01/2014 - 04/2013
2	Body Weight (Weight, Body) 12/2008 - 04/2008
1	Adenocarcinoma 07/2021
1	Duodenal Neoplasms (Duodenal Cancer) 07/2021
1	Pouchitis 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Paralysis (Palsy) 01/2021
1	Frailty 01/2021

Drug/Important Bio-Agent (IBA)

39	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2008
18	MicroRNAs (MicroRNA)IBA 03/2022 - 03/2014
14	Proteins (Proteins, Gene)FDA Link 04/2022 - 08/2010
12	C-Reactive ProteinIBA 12/2021 - 12/2008
11	Biological ProductsIBA 12/2019 - 07/2009
11	Messenger RNA (mRNA)IBA 12/2017 - 08/2010
10	RNA (Ribonucleic Acid)IBA 12/2018 - 03/2011
7	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 05/2012
6	Small Interfering RNA (siRNA)IBA 10/2020 - 03/2010
5	Serum AlbuminIBA 01/2021 - 04/2008
5	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
5	Calcibiotic Root Canal SealerIBA 01/2020 - 03/2015
5	CytokinesIBA 01/2019 - 02/2014
4	Long Noncoding RNAIBA 10/2020 - 12/2014
4	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 06/2008
4	EnzymesIBA 12/2018 - 07/2009
4	Green Fluorescent ProteinsIBA 01/2015 - 01/2012
4	Formaldehyde (Formol)FDA Link 10/2014 - 12/2009
4	ParaffinIBA 10/2014 - 12/2009
3	imidazoleacetic acid (IMAC)IBA 01/2021 - 04/2018
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2019 - 11/2012
3	LigandsIBA 03/2019 - 08/2010
3	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2019 - 01/2015
3	AlbuminsIBA 01/2018 - 10/2017
3	Carcinoembryonic AntigenIBA 10/2017 - 12/2008
3	Red Fluorescent ProteinIBA 11/2012 - 01/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2012 - 10/2009
2	InterleukinsIBA 01/2019 - 02/2014
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
2	immune RNA (I-RNA)IBA 01/2019 - 01/2018
2	Immunoglobulin A (IgA)IBA 01/2019 - 11/2018
2	Inosine FDA Link 01/2019 - 01/2018
2	Fish OilsIBA 01/2018 - 01/2017
2	GlobulinsIBA 01/2018 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2012
2	Angiopoietin-Like Protein 2IBA 12/2015 - 12/2014
2	Untranslated RNA (Noncoding RNA)IBA 10/2015 - 12/2014
2	CurcuminIBA 05/2015 - 03/2015
2	LipopolysaccharidesIBA 01/2015 - 02/2014
2	Phosphotransferases (Kinase)IBA 01/2014 - 01/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2012 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 10/2009
2	Pharmaceutical PreparationsIBA 01/2012 - 08/2011
2	AntibodiesIBA 04/2011 - 11/2010
2	ImmunosorbentsIBA 03/2011 - 07/2009
1	KinesinsIBA 04/2022
1	N-methyladenosineIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 07/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	mitomycin C-immunoglobulin M antibody conjugateIBA 01/2021

Therapy/Procedure

26	Chemoradiotherapy 01/2021 - 10/2009
16	Drug Therapy (Chemotherapy) 07/2021 - 11/2010
12	Therapeutics 01/2021 - 10/2009
9	Neoadjuvant Therapy 05/2021 - 04/2012
7	Lasers (Laser) 04/2016 - 08/2011
5	Gastrectomy 01/2021 - 06/2019
4	Restorative Proctocolectomy 01/2021 - 02/2014
4	Palliative Care (Palliative Therapy) 08/2019 - 01/2017
3	Esophagectomy 01/2021 - 04/2011
3	Colectomy 01/2019 - 11/2014
2	Aftercare (After-Treatment) 04/2016 - 01/2003
2	Colonic Pouches (S Pouch) 11/2014 - 02/2014
2	Laparotomy 03/2014 - 10/2007
2	Radiotherapy 05/2013 - 11/2011
1	Complementary Therapies (Alternative Medicine) 07/2021
1	Perioperative Period 01/2021